Zhengye Biotechnology Holding (ZYBT) Shareholder's Equity (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) Shareholder's Equity (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.23 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.75 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 446.17 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.21 Bn
10 Zhengye Biotechnology Holding 5.49 Mn 6.20 Mn - 43.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 43.24 Mn
Jun 30, 2025 50.97 Mn
Dec 31, 2024 49.08 Mn
Dec 31, 2023 47.12 Mn